supp.ai
Discover Supplement-Drug Interactions
Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 5 years ago
supplement:
Leucine
drug:
Tralokinumab
Research Papers that Mention the Interaction
“Absolute forced expiratory … patients receiving tralokinumab at ….14 L , 95% confidence interval [CI] 0.08,0.21) and 600 mg every 2 weeks (MD 0.20 L, 95% CI … percentage changes (MD 5.82 %, 95% CI 3.58, 8.06; MD 11.8 %, 95% CI 0.79, 22.81).”
The Safety and Efficacy of Anti-IL-13 Treatment with Tralokinumab (CAT-354) in Moderate to Severe Asthma: A Systematic Review and Meta-analysis.
Help us improve supp.ai, we'd love to hear your feedback: Submit Feedback